BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male mice.

MLA

Lee, Hyemi, et al. “BRD2‐specific Inhibitor, BBC0403, Inhibits the Progression of Osteoarthritis Pathogenesis in Osteoarthritis‐induced C57BL/6 Male Mice.” British Journal of Pharmacology, vol. 181, no. 15, Aug. 2024, pp. 2528–44. EBSCOhost, https://doi.org/10.1111/bph.16359.

APA

Lee, H., Nam, J., Jang, H., Park, Y., Son, M., Lee, I., Eyun, S., Yang, J., Jeon, J., & Yang, S. (2024). BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male mice. British Journal of Pharmacology, 181(15), 2528–2544. https://doi.org/10.1111/bph.16359

Chicago

Lee, Hyemi, Jiho Nam, Hahyeong Jang, Young‐Sik Park, Min‐Hee Son, In‐Hyun Lee, Seong‐il Eyun, Jae‐Hyun Yang, Jimin Jeon, and Siyoung Yang. 2024. “BRD2‐specific Inhibitor, BBC0403, Inhibits the Progression of Osteoarthritis Pathogenesis in Osteoarthritis‐induced C57BL/6 Male Mice.” British Journal of Pharmacology 181 (15): 2528–44. doi:10.1111/bph.16359.